
Teladoc Faces Structural Challenges as Telemedicine Market Matures
Teladoc's stock plummeted 98% as telemedicine demand normalized post-pandemic. The company faces structural challenges, slower growth, profitability issues, and intensifying competition from larger healthcare providers.
AMZNTDOCstock declinecompetition